Several genes regulated by RUNX1 or CEBPA demonstrated a significant increase in DNA methylation and a decrease in expression in AML patients with RUNX1 or CEBPA mutation, respectively (Supplementary Tables S3 and S4). This evidence concerns the gene CEBPA and acute myeloid leukemia.